Targeting Aminophospholipids Exposed on Tumor Endothelium for Tumor Imaging

dc.contributor.advisorThorpe, Philip E.en
dc.creatorStafford, Jason Hughen
dc.date.accessioned2012-07-20T20:13:15Z
dc.date.available2012-07-20T20:13:15Z
dc.date.issued2012-07-20
dc.description.abstractAdvances in noninvasive imaging of human cancer are crucial to improving diagnosis and therapeutic planning. My project was aimed at developing novel imaging agents that target the aminophospholipidsphosphatidylserine (PS) and phosphatidylethanolamine (PE). PS and PE arenormally intracellular, but become exposed on the surface of tumor endothelial cells (EC). Anti-tumor therapies promote exposure of PS and PE on tumor EC and the tumor cells as well. Therefore, I tested the hypothesis that 1N11, a PS-binding antibody, and duramycin, a PE-binding peptide, could function as tumor imaging agents. I labeled the F(ab')₂ fragment of 1N11 with the near-infrared fluophore 800CW for optical imaging and the positron emitting isotope iodine-124 (¹²⁴I) for PET imaging. 800CW-1N11 F(ab')₂ clearly imaged subcutaneous and orthotopic U87 gliomas growing in mice with optimal tumor contrast obtained at 24 h post-injection (p.i.). Uptake of 800CW-1N11 F(ab')₂ was approximately 2-fold higher in irradiated U87 tumors. ¹²⁴I-1N11 F(ab')₂ clearly imaged subcutaneous and orthotopic PC3 prostate carcinomas growing in mice with optimal tumor contrast obtained at 48 hr p.i. Importantly, 800CW- and ¹²⁴I-1N11 F(ab')₂ exhibited low uptake in non-target organs (i.e. liver and kidneys). Unlike PS, PE had not been established as a specific marker of tumor vasculature in the literature. To demonstrate PE was such a marker, I biotinylated duramycin, characterized its binding properties, and used it to determine the distribution of PE on EC in vitro and in vivo. Exposure of cultured EC to hypoxia, acidity, reactive oxygen species, or irradiation resulted in the formation of membrane blebs that were intensely PE-positive. When biotinylated duramycin was intravenously injected into tumor-bearing mice it preferentially localized to the luminal surface of the vascular endothelium in multiple tumor models. PE-positive vessels were observed in and around hypoxic regions of the tumor. With the exception of intertubular vessels of the kidney, normal vessels remained unstained. I also conjugated duramycin to 800CW and used it for optical imaging of RM-9 and TRAMP prostate carcinomas. These results demonstrate that both 1N11 and duramycin can be used to image a variety of tumors and warrant further study as imaging agents.en
dc.identifier.oclc811245705
dc.identifier.urihttps://hdl.handle.net/2152.5/1038
dc.language.isoenen
dc.subjectPhosphatidylethanolaminesen
dc.subjectEndothelium, Vascularen
dc.subjectNeoplasmsen
dc.titleTargeting Aminophospholipids Exposed on Tumor Endothelium for Tumor Imagingen
dc.typeThesisen
dc.type.materialTexten
thesis.date.available2012-01-14
thesis.degree.departmentGraduate School of Biomedical Sciencesen
thesis.degree.disciplineCell Regulationen
thesis.degree.grantorUT Southwestern Medical Centeren
thesis.degree.levelDoctoralen
thesis.degree.nameDoctor of Philosophyen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
StaffordJason.pdf
Size:
40.3 MB
Format:
Adobe Portable Document Format
Description:
Available after 1/14/2012

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
834 B
Format:
Item-specific license agreed upon to submission
Description: